0000950170-23-067149.txt : 20231201 0000950170-23-067149.hdr.sgml : 20231201 20231201080004 ACCESSION NUMBER: 0000950170-23-067149 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231129 FILED AS OF DATE: 20231201 DATE AS OF CHANGE: 20231201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Imran Talat CENTRAL INDEX KEY: 0001869579 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40672 FILM NUMBER: 231457552 MAIL ADDRESS: STREET 1: C/O RANI THERAPEUTICS HOLDINGS, INC. STREET 2: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Rani Therapeutics Holdings, Inc. CENTRAL INDEX KEY: 0001856725 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 BUSINESS PHONE: (408) 457-3700 MAIL ADDRESS: STREET 1: 2051 RINGWOOD AVENUE CITY: SAN JOSE STATE: CA ZIP: 95131 4 1 ownership.xml 4 X0508 4 2023-11-29 0001856725 Rani Therapeutics Holdings, Inc. RANI 0001869579 Imran Talat C/O RANI THERAPEUTICS LLC 2051 RINGWOOD AVE. SAN JOSE CA 95131 true true false false Chief Executive Officer false Class A Common Stock 2023-11-29 4 P false 20000 2.05 A 469455 D Includes 12,343 shares held by VH Moll, L.P. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein. /s/ Talat Imran 2023-12-01